AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
373 hedge funds and large institutions have $7.06B invested in Amedisys in 2021 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 131 increasing their positions, 139 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $7.52B → $7.06B (-$459M)
20% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 56
56% less call options, than puts
Call options by funds: $20.3M | Put options by funds: $46.3M
Holders
373
Holding in Top 10
1
Calls
$20.3M
Puts
$46.3M
Top Buyers
| 1 | +$85.4M | |
| 2 | +$48.9M | |
| 3 | +$25M | |
| 4 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$24.2M |
| 5 |
JP Morgan Chase
New York
|
+$23.8M |
Top Sellers
| 1 | -$46.6M | |
| 2 | -$41.3M | |
| 3 | -$33.8M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$27.4M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$25.8M |